AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-96
Results: 26-50/96
BCL-2 EXPRESSION IN PLEURAL AND EXTRAPLEURAL SOLITARY FIBROUS TUMORS
Authors: CHILOSI M FACCHETTI F TOS APD LESTANI M MORASSI ML MARTIGNONI G SORIO C BENEDETTI A MORELLI L DOGLIONI C BARBERIS M MENESTRINA F VIALE G
Citation: M. Chilosi et al., BCL-2 EXPRESSION IN PLEURAL AND EXTRAPLEURAL SOLITARY FIBROUS TUMORS, Journal of pathology, 181(4), 1997, pp. 362-367
MOLECULAR ABNORMALITIES OF THE P53 PATHWAY IN DEDIFFERENTIATED LIPOSARCOMA
Authors: TOS APD DOGLIONI C PICCININ S MAESTRO R MENTZEL T BARBARESCHI M BOIOCCHI M FLETCHER CDM
Citation: Apd. Tos et al., MOLECULAR ABNORMALITIES OF THE P53 PATHWAY IN DEDIFFERENTIATED LIPOSARCOMA, Journal of pathology, 181(1), 1997, pp. 8-13
HPSS - A NEW SILVER STAINING METHOD FOR HELICOBACTER-PYLORI
Authors: DOGLIONI C TURRIN M MACRI E CHIARELLI C GERMANA B BARBARESCHI M
Citation: C. Doglioni et al., HPSS - A NEW SILVER STAINING METHOD FOR HELICOBACTER-PYLORI, Journal of Clinical Pathology, 50(6), 1997, pp. 461-464
P16 CDKN2 AND CDK4 GENE-MUTATIONS IN SPORADIC MELANOMA DEVELOPMENT AND PROGRESSION/
Authors: PICCININ S DOGLIONI C MAESTRO R VUKOSAVLJEVIC T GASPAROTTO D DORAZI C BOIOCCHI M
Citation: S. Piccinin et al., P16 CDKN2 AND CDK4 GENE-MUTATIONS IN SPORADIC MELANOMA DEVELOPMENT AND PROGRESSION/, International journal of cancer, 74(1), 1997, pp. 26-30
HUMAN NON-HODGKINS-LYMPHOMAS OVEREXPRESS A WILD-TYPE FORM OF P53 WHICH IS A FUNCTIONAL TRANSCRIPTIONAL ACTIVATOR OF THE CYCLIN-DEPENDENT KINASE INHIBITOR P21
Authors: MAESTRO R GLOGHINI A DOGLIONI C PICCININ S VUKOSAVLJEVIC T GASPAROTTO D CARBONE A BOIOCCHI M
Citation: R. Maestro et al., HUMAN NON-HODGKINS-LYMPHOMAS OVEREXPRESS A WILD-TYPE FORM OF P53 WHICH IS A FUNCTIONAL TRANSCRIPTIONAL ACTIVATOR OF THE CYCLIN-DEPENDENT KINASE INHIBITOR P21, Blood, 89(7), 1997, pp. 2523-2528
BASALOID-SQUAMOUS CELL-CARCINOMA OF THE LARYNX AND HYPOPHARYNX
Authors: FERLITO A ALTAVILLA G RINALDO A DOGLIONI C
Citation: A. Ferlito et al., BASALOID-SQUAMOUS CELL-CARCINOMA OF THE LARYNX AND HYPOPHARYNX, The Annals of otology, rhinology & laryngology, 106(12), 1997, pp. 1024-1035
MOLECULAR ABERRATIONS OF THE G1-S CHECKPOINT IN MYXOID AND ROUND-CELLLIPOSARCOMA
Authors: TOS APD PICCININ S DOGLIONI C VUKOSAVLJEVIC T MENTZEL T BOIOCCHI M FLETCHER CDM
Citation: Apd. Tos et al., MOLECULAR ABERRATIONS OF THE G1-S CHECKPOINT IN MYXOID AND ROUND-CELLLIPOSARCOMA, The American journal of pathology, 151(6), 1997, pp. 1531-1539
ALPHA-4-BETA-7 INTEGRIN EXPRESSION IS ASSOCIATED WITH THE LEUKEMIC EVOLUTION OF HUMAN AND MURINE T-CELL LYMPHOBLASTIC LYMPHOMAS
Authors: DOLCETTI R GIARDINI R DOGLIONI C CARIATI R POMPONI F DORAZI C RAO S LAZAROVITS AI BUTCHER EC BOIOCCHI M
Citation: R. Dolcetti et al., ALPHA-4-BETA-7 INTEGRIN EXPRESSION IS ASSOCIATED WITH THE LEUKEMIC EVOLUTION OF HUMAN AND MURINE T-CELL LYMPHOBLASTIC LYMPHOMAS, The American journal of pathology, 150(5), 1997, pp. 1595-1605
PROGNOSTIC VALUE OF P21(WAF1) AND P53 EXPRESSION IN BREAST-CARCINOMA - AN IMMUNOHISTOCHEMICAL STUDY IN 261 PATIENTS WITH LONG-TERM FOLLOW-UP
Authors: CAFFO O DOGLIONI C VERONESE S BONZANINI M MARCHETTI A BUTTITTA F FINA P LEEK R MORELLI L DALLAPALMA P HARRIS AL BARBARESCHI M
Citation: O. Caffo et al., PROGNOSTIC VALUE OF P21(WAF1) AND P53 EXPRESSION IN BREAST-CARCINOMA - AN IMMUNOHISTOCHEMICAL STUDY IN 261 PATIENTS WITH LONG-TERM FOLLOW-UP, Clinical cancer research, 2(9), 1996, pp. 1591-1599
P21(WAF1) AND P53 IMMUNOHISTOCHEMICAL EXPRESSION IN BREAST-CARCINOMA MAY PREDICT THERAPEUTIC RESPONSE TO ADJUVANT TREATMENT
Authors: BARBARESCHI M DOGLIONI C VERONESE S BONZANINI M DALLAPALMA P HARRIS AL CAFFO O
Citation: M. Barbareschi et al., P21(WAF1) AND P53 IMMUNOHISTOCHEMICAL EXPRESSION IN BREAST-CARCINOMA MAY PREDICT THERAPEUTIC RESPONSE TO ADJUVANT TREATMENT, European journal of cancer, 32A(12), 1996, pp. 2182-2183
THE KINEMATIC PARADOX OF THE SAN-ANDREAS FAULT
Authors: DOGLIONI C HARABAGLIA P
Citation: C. Doglioni et P. Harabaglia, THE KINEMATIC PARADOX OF THE SAN-ANDREAS FAULT, Terra nova, 8(6), 1996, pp. 525-531
A GEODYNAMIC MODEL OF THE SOUTHERN APENNINES ACCRETIONARY PRISM
Authors: DOGLIONI C HARABAGLIA P MARTINELLI G MONGELLI F ZITO G
Citation: C. Doglioni et al., A GEODYNAMIC MODEL OF THE SOUTHERN APENNINES ACCRETIONARY PRISM, Terra nova, 8(6), 1996, pp. 540-547
P21 RNA AND PROTEIN EXPRESSION IN NON-SMALL-CELL LUNG CARCINOMAS - EVIDENCE OF P53-INDEPENDENT EXPRESSION AND ASSOCIATION WITH TUMORAL DIFFERENTIATION
Authors: MARCHETTI A DOGLIONI C BARBARESCHI M BUTTITTA F PELLEGRINI S BERTACCA G CHELLA A MERLO G ANGELETTI CA DALLAPALMA P BEVILACQUA G
Citation: A. Marchetti et al., P21 RNA AND PROTEIN EXPRESSION IN NON-SMALL-CELL LUNG CARCINOMAS - EVIDENCE OF P53-INDEPENDENT EXPRESSION AND ASSOCIATION WITH TUMORAL DIFFERENTIATION, Oncogene, 12(6), 1996, pp. 1319-1324
STRUCTURAL EVOLUTION OF THE EASTERN BALKANS (BULGARIA)
Authors: DOGLIONI C BUSATTA C BOLIS G MARIANINI L ZANELLA M
Citation: C. Doglioni et al., STRUCTURAL EVOLUTION OF THE EASTERN BALKANS (BULGARIA), Marine and petroleum geology, 13(2), 1996, pp. 225-251
CALRETININ - A NOVEL IMMUNOCYTOCHEMICAL MARKER FOR MESOTHELIOMA
Authors: DOGLIONI C TOS APD LAURINO L IUZZOLINO P CHIARELLI C CELIO MR VIALE G
Citation: C. Doglioni et al., CALRETININ - A NOVEL IMMUNOCYTOCHEMICAL MARKER FOR MESOTHELIOMA, The American journal of surgical pathology, 20(9), 1996, pp. 1037-1046
INVOLVEMENT OF BCL-2 ONCOPROTEIN IN THE DEVELOPMENT OF ENTEROCHROMAFFIN-LIKE CELL GASTRIC CARCINOIDS
Authors: AZZONI C DOGLIONI C VIALE G DELLEFAVE G DEBONI M CARUANA P FERRARO G BORDI C
Citation: C. Azzoni et al., INVOLVEMENT OF BCL-2 ONCOPROTEIN IN THE DEVELOPMENT OF ENTEROCHROMAFFIN-LIKE CELL GASTRIC CARCINOIDS, The American journal of surgical pathology, 20(4), 1996, pp. 433-441
BCL-2 AND P53 EXPRESSION IN NODE-NEGATIVE BREAST-CARCINOMA - A STUDY WITH LONG-TERM FOLLOW-UP
Authors: BARBARESCHI M CAFFO O VERONESE S LEEK RD FINA P FOX S BONZANINI M GIRLANDO S MORELLI L ECCHER C PEZZELLA F DOGLIONI C PALMA PD HARRIS A
Citation: M. Barbareschi et al., BCL-2 AND P53 EXPRESSION IN NODE-NEGATIVE BREAST-CARCINOMA - A STUDY WITH LONG-TERM FOLLOW-UP, Human pathology, 27(11), 1996, pp. 1149-1155
EVALUATION OF STRESSES IN 2 GEODYNAMICALLY DIFFERENT AREAS - STABLE FORELAND AND EXTENSIONAL BACKARC
Authors: DRAGONI M DOGLIONI C MONGELLI F ZITO G
Citation: M. Dragoni et al., EVALUATION OF STRESSES IN 2 GEODYNAMICALLY DIFFERENT AREAS - STABLE FORELAND AND EXTENSIONAL BACKARC, Pure and Applied Geophysics, 146(2), 1996, pp. 319-341
MOLECULAR ABERRATIONS IN DEDIFFERENTIATED LIPOSARCOMA
Authors: DEITOS AP MAESTRO R DOGLIONI C MENTZEL T MACRI A FLETCHER CDM
Citation: Ap. Deitos et al., MOLECULAR ABERRATIONS IN DEDIFFERENTIATED LIPOSARCOMA, Laboratory investigation, 74(1), 1996, pp. 11-11
P21(WAF1) EXPRESSION IN NORMAL AND PATHOLOGICAL COLONIC MUCOSA
Authors: DOGLIONI C DELTOS AP PELOSIO P LAURINO L MACRI E MEGGIOLARO E BARBARESCHI M
Citation: C. Doglioni et al., P21(WAF1) EXPRESSION IN NORMAL AND PATHOLOGICAL COLONIC MUCOSA, Laboratory investigation, 74(1), 1996, pp. 313-313
CALRETININ - A NOVEL IMUNOCYTOCHEMICAL MARKER OF NEURONAL DIFFERENTIATION IN TUMORS OF THE BRAIN
Authors: DOGLIONI C TOS APD FURLANETTO A MUFFATO G CHIARELLI C MACRI E ARRIGONI A
Citation: C. Doglioni et al., CALRETININ - A NOVEL IMUNOCYTOCHEMICAL MARKER OF NEURONAL DIFFERENTIATION IN TUMORS OF THE BRAIN, Laboratory investigation, 74(1), 1996, pp. 818-818
P21 WAF1/CIP1 EXPRESSION IN NORMAL MUCOSA AND IN ADENOMAS AND ADENOCARCINOMAS OF THE COLON - ITS RELATIONSHIP WITH DIFFERENTIATION/
Authors: DOGLIONI C PELOSIO P LAURINO L MACRI E MEGGIOLARO E FAVRETTI F BARBARESCHI M
Citation: C. Doglioni et al., P21 WAF1/CIP1 EXPRESSION IN NORMAL MUCOSA AND IN ADENOMAS AND ADENOCARCINOMAS OF THE COLON - ITS RELATIONSHIP WITH DIFFERENTIATION/, Journal of pathology, 179(3), 1996, pp. 248-253
CHROMOSOME 13Q DELETION MAPPING IN HEAD AND NECK SQUAMOUS-CELL CARCINOMAS - IDENTIFICATION OF 2 DISTINCT REGIONS OF PREFERENTIAL LOSS
Authors: MAESTRO R PICCININ S DOGLIONI C GASPAROTTO D VUKOSAVLJEVIC T SULFARO S BARZAN L BOIOCCHI M
Citation: R. Maestro et al., CHROMOSOME 13Q DELETION MAPPING IN HEAD AND NECK SQUAMOUS-CELL CARCINOMAS - IDENTIFICATION OF 2 DISTINCT REGIONS OF PREFERENTIAL LOSS, Cancer research, 56(5), 1996, pp. 1146-1150
P21(WAF1) IMMUNOHISTOCHEMICAL EXPRESSION IN BREAST-CARCINOMA - CORRELATIONS WITH CLINICOPATHOLOGICAL DATA, ESTROGEN-RECEPTOR STATUS, MIB1 EXPRESSION, P53 GENE AND PROTEIN ALTERATIONS AND RELAPSE-FREE SURVIVAL
Authors: BARBARESCHI M CAFFO O DOGLIONI C FINA P MARCHETTI A BUTTITTA F LEEK R MORELLI L LEONARDI E BEVILACQUA G DALLAPALMA P HARRIS AL
Citation: M. Barbareschi et al., P21(WAF1) IMMUNOHISTOCHEMICAL EXPRESSION IN BREAST-CARCINOMA - CORRELATIONS WITH CLINICOPATHOLOGICAL DATA, ESTROGEN-RECEPTOR STATUS, MIB1 EXPRESSION, P53 GENE AND PROTEIN ALTERATIONS AND RELAPSE-FREE SURVIVAL, British Journal of Cancer, 74(2), 1996, pp. 208-215
P21 WAF1 CYCLIN-KINASE INHIBITOR EXPRESSION IN NON-HODGKINS-LYMPHOMAS- A POTENTIAL MARKER OF P53 TUMOR-SUPPRESSOR GENE-FUNCTION/
Authors: CHILOSI M DOGLIONI C MAGALINI A INGHIRAMI G KRAMPERA M NADALI G RAHAL D PEDRON S BENEDETTI A SCARDONI M MACRI E LESTANI M MENESTRINA F PIZZOLO G SCARPA A
Citation: M. Chilosi et al., P21 WAF1 CYCLIN-KINASE INHIBITOR EXPRESSION IN NON-HODGKINS-LYMPHOMAS- A POTENTIAL MARKER OF P53 TUMOR-SUPPRESSOR GENE-FUNCTION/, Blood, 88(10), 1996, pp. 4012-4020
Risultati: 1-25 | 26-50 | 51-75 | 76-96